News

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data ...
So when my urologist said in 2019 that my PSA test showed the most aggressive form of prostate cancer, I was not prepared. I was 68, and my annual tests had always been normal. Soon I embarked on a ...
A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...
Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of serious mental health risks.
Hormone therapy for prostate cancer is aimed at reducing or eliminating the amount of testosterone in your body to slow or stop prostate cancer cells from growing and multiplying. Hormone therapy ...
Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...
Investigators evaluated the effectiveness of an immunotherapy in combination with standard radiation therapy for patients with intermediate-high risk localized prostate cancer.
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted ...
Background: Intermittent (i) and continuous (c) androgen deprivation therapy (ADT) not only play a critical role in managing prostate cancer (PC) but also impact patient’s quality of life (QoL). This ...
The effectiveness of primary androgen-deprivation therapy (PADT) for clinically localized prostate cancer has been found lacking. A retrospective cohort study of more than 15,000 men newly ...